Pacifica Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.78K | Sell |
239
-535
| -69% | -$12.9K | ﹤0.01% | 382 |
|
|
2025
Q1 | $18.8K | Buy |
774
+8
| +1% | +$194 | 0.01% | 286 |
|
|
2024
Q4 | $20.4K | Sell |
766
-4,016
| -84% | -$107K | 0.01% | 282 |
|
|
2024
Q3 | $138K | Sell |
4,782
-118
| -2% | -$3.42K | 0.06% | 130 |
|
|
2024
Q2 | $136K | Buy |
4,900
+252
| +5% | +$6.98K | 0.06% | 133 |
|
|
2024
Q1 | $127K | Sell |
4,648
-216
| -4% | -$5.92K | 0.06% | 132 |
|
|
2023
Q4 | $141K | Buy |
4,864
+337
| +7% | +$9.8K | 0.07% | 121 |
|
|
2023
Q3 | $152K | Buy |
4,527
+1,750
| +63% | +$58.6K | 0.08% | 111 |
|
|
2023
Q2 | $101K | Buy |
2,777
+5
| +0.2% | +$182 | 0.06% | 124 |
|
|
2023
Q1 | $115K | Buy |
2,772
+170
| +7% | +$7.03K | 0.07% | 117 |
|
|
2022
Q4 | $133K | Buy |
2,602
+132
| +5% | +$6.76K | 0.09% | 104 |
|
|
2022
Q3 | $110K | Hold |
2,470
| – | – | 0.08% | 115 |
|
|
2022
Q2 | $127K | Buy |
2,470
+8
| +0.3% | +$411 | 0.09% | 115 |
|
|
2022
Q1 | $117K | Hold |
2,462
| – | – | 0.08% | 120 |
|
|
2021
Q4 | $138K | Buy |
2,462
+3
| +0.1% | +$168 | 0.09% | 111 |
|
|
2021
Q3 | $108K | Buy |
2,459
+4
| +0.2% | +$176 | 0.08% | 111 |
|
|
2021
Q2 | $96K | Buy |
2,455
+5
| +0.2% | +$196 | 0.07% | 111 |
|
|
2021
Q1 | $88K | Buy |
2,450
+5
| +0.2% | +$180 | 0.07% | 108 |
|
|
2020
Q4 | $92K | Sell |
2,445
-128
| -5% | -$4.82K | 0.09% | 96 |
|
|
2020
Q3 | $90K | Buy |
2,573
+4
| +0.2% | +$140 | 0.1% | 89 |
|
|
2020
Q2 | $84K | Buy |
2,569
+331
| +15% | +$10.8K | 0.09% | 93 |
|
|
2020
Q1 | $71K | Sell |
2,238
-105
| -4% | -$3.33K | 0.09% | 105 |
|
|
2019
Q4 | $87K | Buy |
+2,343
| New | +$87K | 0.08% | 106 |
|